New #research from the @JohnPulikkan Lab unlocks new possibilities for gene-targeted therapies in people with inv(16) acute myeloid #leukemia (AML) and other AML subtypes. These important findings were recently published in @ScienceAdvances.
Learn more: https://t.co/9cC8g2PQKC
.@BloodResearchWI’s @JohnPulikkan was recently awarded $792k from @AmericanCancer to understand how mutations in the gene CEBPA cause #leukemia, which will help researchers improve outcomes for patients.